| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DIACARE.27.10.2498 |
| P698 | PubMed publication ID | 15451925 |
| P2093 | author name string | Giovanni Targher | |
| Lorenzo Bertolini | |||
| Luciano Zenari | |||
| Giacomo Zoppini | |||
| Roberto Padovani | |||
| Giancarlo Falezza | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | steatosis | Q1365091 |
| P304 | page(s) | 2498-2500 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation | |
| P478 | volume | 27 |
| Q28387404 | Arsenic and cardiovascular disease |
| Q58622719 | Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious |
| Q37192191 | Assessment of Vitamin D status in a group of Egyptian children with non alcoholic fatty liver disease (multicenter study). |
| Q51901149 | Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging. |
| Q34976232 | Association between inflammatory markers and liver fat: The Multi-Ethnic Study of Atherosclerosis |
| Q61958585 | Association between non-alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community |
| Q40683530 | Association between nonalcoholic fatty liver disease and carotid atherosclerosis: a meta-analysis |
| Q37282849 | Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events |
| Q35289060 | Association between retinal artery lesions and nonalcoholic fatty liver disease |
| Q90734876 | Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review |
| Q37386514 | Carotid lesions in outpatients with nonalcoholic fatty liver disease |
| Q28547365 | Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis |
| Q26777147 | Comorbidities and Metabolic Derangement of NAFLD |
| Q81858328 | Current literature in diabetes |
| Q92135373 | Determination of association between nonalcoholic fatty liver disease and carotid artery atherosclerosis among nondiabetic individuals |
| Q33596784 | Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis. |
| Q98159487 | Endothelial Dysfunction, a Marker of Atherosclerosis, Is Independent of Metabolic Syndrome in NAFLD Patients |
| Q36898693 | Evaluation and management of obesity-related nonalcoholic fatty liver disease |
| Q40163524 | Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease |
| Q30433376 | Fatty liver, carotid disease and gallstones: a study of age-related associations |
| Q36501848 | First-degree relatives of patients with type 2 diabetes mellitus and risk of non-alcoholic Fatty liver disease |
| Q37483740 | Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload. |
| Q40706265 | Hard clinical outcomes in patients with NAFLD. |
| Q37310401 | Hepatic extracellular signal-regulated kinase 2 suppresses endoplasmic reticulum stress and protects from oxidative stress and endothelial dysfunction |
| Q33375822 | Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study |
| Q43267351 | Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO Study |
| Q35848217 | Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study |
| Q36796750 | Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease |
| Q38008136 | Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. |
| Q37258329 | Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? |
| Q61451356 | Influence of Visceral Obesity and Liver Fat on Vascular Structure and Function in Obese Subjects |
| Q47804370 | Levels of soluble CD40 ligand and P-Selectin in nonalcoholic fatty liver disease |
| Q39867039 | Lipid metabolism and inflammation modulated by Vitamin D in liver of diabetic rats |
| Q36427402 | Liver fat content is negatively associated with atherosclerotic carotid plaque in type 2 diabetic patients |
| Q36859567 | Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease |
| Q42097807 | Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease |
| Q37886792 | Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease |
| Q37935278 | NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages |
| Q80964439 | NASH predicts plasma inflammatory biomarkers independently of visceral fat in men |
| Q36399368 | Non-Alcoholic Fatty Liver Disease, a Marker of Subclinical Atherosclerosis Applicable Only to Metabolic Syndrome?: Time to Organize the Connection between Metabolism and Atherosclerosis |
| Q94479096 | Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance |
| Q82909029 | Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients |
| Q33308506 | Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients |
| Q35971067 | Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis |
| Q80415635 | Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: Another piece of the puzzle |
| Q36839916 | Nonalcoholic fatty liver disease and cardiovascular disease risk |
| Q37318761 | Nonalcoholic fatty liver disease and cardiovascular risk |
| Q27692035 | Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. |
| Q33913788 | Nonalcoholic fatty liver disease as a comorbidity of childhood obesity |
| Q37430287 | Osteoporosis and cardiovascular diseases' cosegregation: epidemiological features. |
| Q30485888 | Parametric exploration of the liver by magnetic resonance methods |
| Q38090905 | Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis |
| Q36316335 | Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering? |
| Q36399373 | Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients |
| Q37794163 | Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease |
| Q37596189 | Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease |
| Q34778776 | Risk stratification of non-contrast CT beyond the coronary calcium scan |
| Q36952308 | Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. |
| Q40244259 | The association between retinal microvascular changes, metabolic risk factors, and liver histology in pediatric patients with non-alcoholic fatty liver disease (NAFLD). |
| Q33596745 | The effect of an aerobic exercise on serum level of liver enzymes and liver echogenicity in patients with non alcoholic fatty liver disease |
| Q34335282 | The effect of bariatric surgeries on nonalcoholic fatty liver disease |
| Q34951495 | The g0/g1 switch gene 2 is an important regulator of hepatic triglyceride metabolism |
| Q36716912 | The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. |
| Q37272567 | The plasma lipidomic signature of nonalcoholic steatohepatitis |
| Q33610786 | Viewpoints on the way to a consensus session: where does insulin resistance start? The liver |
Search more.